Skip to main content
. Author manuscript; available in PMC: 2018 Jan 1.
Published in final edited form as: Transplantation. 2017 Jan;101(1):131–140. doi: 10.1097/TP.0000000000001076

Table 1C. Distribution of induction and maintenance immunosuppressants.

N (%) N (%) N (%) N (%) N (%)
INDUCTION TOTAL Thymo Campath None
Training set Pre-transplant 49 (100) 29 (59.2) 10 (20.4) 10 (20.4)
Validation set Pre-transplant 33 (100) 19 (57.5) 1 (3) 13 (39.4)
p-value* 0.999 (NS) 0.043 0.080 (NS)
Training set Post-transplant 98 (100) 54 (55.1) 11 (11.2) 33 (33.7)
Validation set Post-transplant 64 (100) 32 (50) 3 (4.7) 29 (45.3)
p-value* 0.629 (NS) 0.252 (NS) 0.142 (NS)
MAINTENANCE Tacrolimus Steroids Cellcept Rapamycin
Training set Post-transplant 98 (100) 91 (92.8) 36 (36.7) 4 (4.1) 5 (5.1)
Validation set Post-transplant 64 (100) 61 (95.3) 29 (45.3) 0 (0) 2 (3.1)
p-value* 0.741 (NS) 0.326 (NS) 0.154 (NS) 0.705 (NS)
*

p-value Fisher exact test